Literature DB >> 3003237

Classification of Barmah Forest virus as an alphavirus using cytotoxic T cell assays.

A Müllbacher, I D Marshall, P Ferris.   

Abstract

Barmah Forest virus, an arbovirus, does not cross-react convincingly with alpha-, flavi- or bunyavirus immune sera. Secondary cytotoxic T cells generated in vitro immune to a number of alphaviruses cross-lyse Barmah Forest virus-infected target cells. Flavivirus (West Nile and Kunjin)- and Bunyamwera virus-immune Tc cells lyse homologous virus-infected target cells, but not alphavirus-infected targets. Using cytotoxic T cell assays Barmah Forest virus can be classified as an alphavirus.

Entities:  

Mesh：

Year:  1986        PMID： 3003237     DOI： 10.1099/0022-1317-67-2-295

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  6 in total

1.  Differential target cell susceptibility to SFV-immune cytotoxic T-cells.

Authors:  A Müllbacher; N J King
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 2.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

Review 3.  Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity.

Authors:  M Lobigs; R V Blanden; A Müllbacher
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

4.  SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity.

Authors:  Arno Mullbacher; Julian Pardo; Yoichi Furuya
Journal:  Pathogens       Date:  2020-11-10

Review 5.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

6.  MHC class II-alpha chain knockout mice support increased viral replication that is independent of their lack of MHC class II cell surface expression and associated immune function deficiencies.

Authors:  Mohammed Alsharifi; Aulikki Koskinen; Danushka K Wijesundara; Jayaram Bettadapura; Arno Müllbacher
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.